Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)
Status:
Unknown status
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
Due to limited experience with cabazitaxel in TCCU, the study will be started as a randomised
phase II study. The aim of the phase II study is to evaluate if the response rates (CR + PR)
are sufficiently high to further study the treatment regimens in a phase III setting.